Cargando…
A chemotherapeutic approach targeting the acidic tumor microenvironment: combination of a proton pump inhibitor and paclitaxel for statistically optimized nanotherapeutics
Paclitaxel (PTX) is a major chemotherapeutic drug that is effective against a wide variety of cancers, particularly breast, ovarian and lung cancer. For a weakly basic chemotherapeutic drug such as PTX, the development of the acidic tumor microenvironment (Warburg effect) has a remarkable impact on...
Autores principales: | Bhattacharya, Saswati, Khanam, Jasmina, Sarkar, Pradipta, Pal, Tapan Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059297/ https://www.ncbi.nlm.nih.gov/pubmed/35521568 http://dx.doi.org/10.1039/c8ra08924h |
Ejemplares similares
-
Application of statistical design to evaluate critical process parameters and optimize formulation technique of polymeric nanoparticles
por: Sarkar, Pradipta, et al.
Publicado: (2019) -
Proton Pump Inhibition Enhances the Cytotoxicity of Paclitaxel in Cervical Cancer
por: Song, Taejong, et al.
Publicado: (2017) -
Nanotherapeutics in the EU: an overview on current state and future directions
por: Hafner, Anita, et al.
Publicado: (2014) -
Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review
por: Zhao, Xingtao, et al.
Publicado: (2023) -
Correction: Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review
por: Zhao, Xingtao, et al.
Publicado: (2023)